A Look At Alignment Healthcare (ALHC) Valuation After The Recent 13.2 Million Share Secondary Offering

Simply Wall St.

Yesterday

Alignment Healthcare (ALHC) is back in focus after an existing stockholder sold about 13.2 million shares in a secondary offering, increasing public float and liquidity without adding new capital to ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2618627606"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2618627606\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2618627606?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151","is_english":true,"pubTime":"2026-03-09 22:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2618627606","market":"sg","top_or_hot":-1,"title":"A Look At Alignment Healthcare (ALHC) Valuation After The Recent 13.2 Million Share Secondary Offering","media":"Simply Wall St.","content":"<div>\n<p>Alignment Healthcare (ALHC) is back in focus after an existing stockholder sold about 13.2 million shares in a secondary offering, increasing public float and liquidity without adding new capital to ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/a-look-at-alignment-healthcare-alhc-valuation-after-the-rece\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At Alignment Healthcare (ALHC) Valuation After The Recent 13.2 Million Share Secondary Offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At Alignment Healthcare (ALHC) Valuation After The Recent 13.2 Million Share Secondary Offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-09 22:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/a-look-at-alignment-healthcare-alhc-valuation-after-the-rece><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Alignment Healthcare (ALHC) is back in focus after an existing stockholder sold about 13.2 million shares in a secondary offering, increasing public float and liquidity without adding new capital to ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/a-look-at-alignment-healthcare-alhc-valuation-after-the-rece\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/a-look-at-alignment-healthcare-alhc-valuation-after-the-rece","article_id":"2618627606","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/a-look-at-alignment-healthcare-alhc-valuation-after-the-rece","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2618627606","pubTimestamp":1773066015,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Alignment Healthcare (ALHC) is back in focus after an existing stockholder sold about 13.2 million shares in a secondary offering, increasing public float and liquidity without adding new capital to the company.\nSee our latest analysis for Alignment Healthcare.\nThe secondary sale and recent shelf registration have come alongside mixed price action, with the 1 month share price return of 15.22% and year to date share price return of 8.8% contrasting with a 1 year total shareholder return of...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4539":"次新股","BK4585":"ETF&股票定投概念","BK4154":"管理型保健护理","XBI":"SPDR S&P Biotech ETF","LABU":"三倍做多标普生物-Direxion","ALHC":"Alignment Healthcare, Inc.","BK4581":"高盛持仓","XLV":"健康照护类股ETF-SPDR"},"translate_title":"Alignment Healthcare(ALHC)最近二次发行1,320万股后的估值一览","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XBI":0.6,"ALHC":1.5,"LABU":0.6,"XLV":1.5},"content_text":"Alignment Healthcare (ALHC) is back in focus after an existing stockholder sold about 13.2 million shares in a secondary offering, increasing public float and liquidity without adding new capital to the company. See our latest analysis for Alignment Healthcare. The secondary sale and recent shelf registration have come alongside mixed price action, with the 1 month share price return of 15.22% and year to date share price return of 8.8% contrasting with a 1 year total shareholder return of 22.77% and a very large 3 year total shareholder return of about 19x. This suggests longer term momentum has been strong even as the latest offering and guidance reset near term expectations around risk and growth. If this secondary offering has you reassessing healthcare exposure, it could be a good time to scan our 32 healthcare AI stocks for fresh ideas in the space. With Alignment Healthcare trading at $18.44 against an analyst price target of $25.50 and an estimated intrinsic value gap flagged at around 65%, you have to ask: is there a genuine opportunity here, or is the market already banking on future growth? AdvertisementMost Popular Narrative: 27.4% Undervalued With Alignment Healthcare’s fair value narrative sitting at $25.42 against a last close of $18.44, the current price sits well below that framework.  Alignment's robust, technology-enabled care model and investments in administrative automation, workflow standardization, and digital health platforms position the company to significantly lower SG&A expenses and improve scalability, likely powering both margin expansion and earnings growth over the next several years.  Read the complete narrative. Curious what kind of revenue ramp, margin shift, and earnings profile are baked into that fair value? The narrative leans on bold, multi year compounding assumptions. Result: Fair Value of $25.42 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, those fair value assumptions depend heavily on Medicare Advantage policy remaining supportive and membership growth holding up, even as competition and regulatory scrutiny increase. Find out about the key risks to this Alignment Healthcare narrative. Next Steps Given the mix of optimism and caution running through this story, it makes sense to look at the numbers yourself and not just the headlines. If you want a clear sense of both the upside and the downside before you move on, take a close look at our breakdown of 5 key rewards and 1 important warning sign. Looking for more investment ideas? If you are weighing what to do next after reading this, do not stop at a single stock when there is a whole market of options to compare.  Start by hunting for quality at a discount with our 50 high quality undervalued stocks, so you are not relying on just one potential opportunity. Prioritise stability and sleep easier at night by scanning the 66 resilient stocks with low risk scores, where the focus is on companies with more resilient profiles. Broaden your watchlist with the screener containing 24 high quality undiscovered gems, so you spot strong businesses before they become everyone else's obvious pick.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}